Omnichannel HCP Engagement Framework: 5 Layers, 90 Days

IQVIA’s econometric analysis of promotional channels found that face-to-face interactions’ contribution to impactable sales dropped from 71% pre-pandemic to 48% post-pandemic, while the ROI of each remaining F2F engagement rose 20% above pre-pandemic levels (per IQVIA’s ChannelDynamics analysis, October 2024). Translation: fewer calls are landing, but the ones that do are more valuable. Meanwhile, IQVIA reports that HCPs in the APAC region, which includes India, show the highest preference for digital engagement post-Covid compared to any other region (per IQVIA ChannelDynamics, MAT January 2024). Add Indegene’s finding that 71% of Indian HCPs feel overwhelmed by pharma content, and over 55% say reps can significantly improve interaction quality (per Indegene’s Digitally-Savvy HCP report), and the picture is clear: your HCPs want fewer, better, better-coordinated interactions across channels. That requires a framework, not another campaign.

For brand managers navigating this shift, the temptation is to launch another digital campaign, add a WhatsApp channel, or commission a webinar series. Each of those is a tactic. What you need is an operating structure that sequences those tactics into a coordinated HCP journey, with explicit hand-offs between layers and measurement checkpoints that tell you whether the framework is working. This post lays out that structure: five layers, end to end, with India-specific channel guidance and a 90-day rollout plan you can execute step by step. If you are also evaluating whether to build this in-house or partner with an agency, our pharmaceutical digital marketing agency evaluation framework covers the capability and compliance questions you should ask.

Why a Framework, Not Another Campaign

Campaigns are episodic by design. A campaign has a start date, a budget, a creative concept, and an end date. When it ends, you measure results, archive the assets, and move on. An omnichannel HCP engagement framework is different. It is a persistent operating model that defines how your brand orchestrates every HCP touchpoint, who owns each hand-off, what data flows between layers, and how you measure whether the whole system is improving HCP engagement quality over time.

The distinction matters because HCPs do not experience your brand as a series of campaigns. They experience it as a stream of interactions: a rep visit on Monday, a WhatsApp message on Wednesday, a webinar invitation on Friday, a medical journal ad the following Tuesday. If those touchpoints are uncoordinated, the HCP experiences noise. Indegene’s data confirms this: 71% of Indian HCPs feel overwhelmed by the volume of pharma content they receive, and the primary drivers of that fatigue are product promotional content and event-related information (per Indegene’s Digitally-Savvy HCP report). More campaigns add to the noise. A framework reduces it by ensuring each touchpoint has a purpose, a sequence, and a feedback loop.

Consider what happens without a framework. Your digital team sends an email blast about a new clinical trial readout. Your field force, operating on a separate call plan, visits the same HCP the next day with a different message about a different brand. The HCP gets two unrelated pitches in 24 hours. The rep does not know the HCP already received the trial data digitally. The digital team does not know the rep is in the field with a conflicting priority. Both teams report activity. Neither reports engagement quality. This is the silo problem that an omnichannel HCP engagement framework is designed to solve.

The market context makes this urgent. Pharmarack reported the Indian pharmaceutical market grew 8.4% in FY25 to over ₹2.25 lakh crore, with cardiac (10.8%), gastrointestinal (10.2%), and anti-diabetic (8%) therapies leading value growth (per Business Standard, citing Pharmarack). IQVIA’s Q2 2025 quarterly insights put the IPM at ₹61,000 crore for the quarter. The market is growing, but the engagement models that capture that growth are changing. Brand managers who build a coordinated framework now will be positioned to compete in a market where HCPs increasingly filter out uncoordinated outreach.

The Five Layers, End to End

The framework is built in five sequential layers. Each layer has a specific owner, a defined input from the previous layer, an explicit hand-off to the next, and a measurement checkpoint. You build them in order because each layer depends on the one below it. Skip a layer, and the structure collapses under its own weight.

Layer	Purpose	Key Inputs	Hand-Off Trigger	Measurement Checkpoint
1. HCP Segmentation and Targeting	Decide which HCPs to engage, at what depth, through which channels	Prescription data (IQVIA or Pharmarack), CRM call history, therapy area priorities	Segmentation matrix approved by brand and sales leadership	Target coverage rate by segment; segment-level engagement rate
2. Content Architecture	Build modular, compliant content mapped to each HCP journey stage	Approved product label, published clinical trial data, UCPMP-compliant messaging framework	Content modules pass medical-legal-regulatory (MLR) review	Content utilization rate (modules used vs. available); module completion rate
3. Channel Orchestration	Sequence touchpoints across channels based on HCP preference and segment	Channel preference data, MR call plan, digital platform capabilities	Journey maps activated in CRM for each HCP segment	Touchpoint frequency vs. target; channel mix adherence rate
4. Data Integration and CRM Sync	Ensure every digital interaction feeds back to the MR dashboard in near real time	CRM platform, marketing automation tool, analytics dashboard	Bidirectional sync confirmed: digital engagements visible to MR within 24 hours	CRM sync rate; data completeness score (HCP records with digital + field data)
5. Measurement and Optimization	Track engagement quality and prescription impact; adjust the framework	Engagement metrics, IPM audit data (IQVIA or Pharmarack), test vs. control geography results	Monthly review cycle completed with brand, sales, and analytics	Engagement-to-prescription correlation; cost per engaged HCP; HCP experience score

Layer 1: HCP Segmentation and Targeting

Segmentation is the foundation. If you do not know who you are engaging with and at what depth, every subsequent layer operates on guesswork. Start with prescription data from IQVIA or Pharmarack to rank HCPs by prescribing volume in your therapy area. Cross-reference with CRM call history to identify which HCPs your field force already reaches regularly and which are under-served. Then segment HCPs into tiers: high-value prescribers who need deep, multi-channel engagement; mid-value prescribers who need periodic, content-led engagement; and low-value or non-prescribers who need awareness-level digital touchpoints only.

The hand-off from Layer 1 to Layer 2 is the segmentation matrix: a document that lists each HCP tier, the target HCP count per tier, the target call frequency, and the recommended channel mix. This matrix must be signed off by both brand and sales leadership. Without that dual sign-off, the field force will not adjust call plans to match the segmentation, and the framework breaks at the first hand-off.

No public benchmark exists for how many HCP segments an Indian pharma brand should define. The right number depends on your therapy area complexity, field force size, and data granularity. A company would determine this by starting with prescription deciles from IQVIA or Pharmarack data, testing three to five segments in a pilot geography, and adjusting based on whether the segments produce measurably different engagement patterns.

Layer 2: Content Architecture

Content architecture is not about producing more content. It is about producing modular content that can be assembled into different journeys for different HCP segments. Instead of a single 20-slide detail aid, you build a library of approved content modules: a mechanism-of-action animation, a clinical trial summary card, a safety profile sheet, a patient profile infographic, and a treatment algorithm visual. Each module is tagged by HCP journey stage (awareness, consideration, initiation, adherence), therapy area, and UCPMP compliance status.

Under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, published by the Department of Pharmaceuticals in March 2024, all promotional material must be consistent with the drug’s marketing approval, and claims must be “balanced, up-to-date, verifiable” and “capable of substantiation” on request by medical or pharmacy professionals (UCPMP clauses 1.2 and 1.3). Every content module must pass medical-legal-regulatory (MLR) review before it enters the library. The hand-off from Layer 2 to Layer 3 is the MLR-approved content library, indexed and tagged, ready for channel orchestration.

Layer 3: Channel Orchestration

Channel orchestration is where the framework becomes visible to the HCP. For each HCP segment, you define a journey: a sequenced set of touchpoints across channels, timed to HCP preference and prescribing cycle. A high-value cardiac prescriber might receive a rep visit with the trial data module in week one, a WhatsApp follow-up with the safety profile card in week two, a webinar invitation in week three, and a second rep visit with the treatment algorithm in week five. A mid-value prescriber might receive a shorter sequence: an email with the trial summary, a WhatsApp message with the patient profile, and a webinar invitation.

Indegene’s research found that 68% of HCPs globally prefer webinars or webcasts as their primary channel for receiving information, and that HCPs in India prefer mobile devices for consuming medical and promotional content (per Indegene’s Digitally-Savvy HCP report). Indegene also found that Indian HCPs prefer to be contacted between 8:00 pm and 11:00 pm. Channel orchestration should reflect these preferences: mobile-first content formats, evening timing for asynchronous touchpoints, and webinars positioned as the high-value content channel.

The hand-off from Layer 3 to Layer 4 is the activated journey map in your CRM: for each HCP segment, the planned sequence of touchpoints is loaded, with triggers that fire the next touchpoint based on HCP response. If an HCP opens the WhatsApp message but does not click through, the system triggers a rep follow-up. If the HCP registers for the webinar, the system suppresses the next promotional email and schedules a post-webinar rep visit instead.

Layer 4: Data Integration and CRM Sync

This is the layer most Indian pharma companies skip, and it is the one that makes or breaks the framework. Data integration means that every digital interaction (email open, WhatsApp click, webinar registration, e-detailing completion) flows back to the MR dashboard within 24 hours. When a rep walks into an HCP’s clinic, they should know exactly what digital touchpoints that HCP has received and how they responded. Without this, the rep is flying blind and the digital team is operating in a vacuum.

Our 2025 study of 199 pharma professionals found that MNCs and top-50 IPM players significantly outperform domestic firms in omnichannel orchestration, largely because they have stronger CRM and analytics infrastructure. Domestic firms relied more on low-cost channels like WhatsApp and basic social media but lacked the analytics depth to coordinate those channels with field activity. The CRM sync rate, defined as the percentage of digital engagements that appear in the MR dashboard within 24 hours, is the single most diagnostic metric for whether your omnichannel framework is real or aspirational.

Layer 5: Measurement and Optimization

The final layer closes the loop. Measurement in an omnichannel framework is not about counting activities (emails sent, webinars hosted, WhatsApp messages delivered). It is about tracking engagement quality and linking it to prescription impact. The core metrics are: HCP engagement rate by channel (percentage of targeted HCPs who interact with content), content completion rate (percentage who finish a module or webinar), CRM sync rate (Layer 4), and the correlation between engagement intensity and prescription share movement in your therapy area.

For prescription impact, use IQVIA or Pharmarack audit data to compare prescription share in test geographies (where the framework is active) against control geographies (where traditional rep-led detailing continues). Run the comparison over at least two quarters to account for prescription lag. No public benchmark exists for what constitutes a “good” engagement-to-prescription correlation in Indian pharma. A company would establish its own baseline by measuring the correlation before the framework is deployed, then tracking whether the correlation strengthens as the framework matures.

The hand-off from Layer 5 back to Layer 1 is the monthly review cycle. Based on what the data shows, you adjust segmentation (promote or demote HCPs between tiers), retire underperforming content modules, shift channel mix, and refine journey maps. The framework is not static. It improves with every review cycle.

India-Specific Channel Notes

The five-layer framework is universal in structure, but its execution in India requires attention to channel-specific realities that differ from Western markets. Three areas demand particular care: WhatsApp engagement, consent under the DPDP Act, and the distinction between KOL webinars and accredited CME.

WhatsApp Etiquette for HCP Engagement

WhatsApp is the de facto communication channel for Indian HCP engagement. Indegene’s research confirms that Indian HCPs prefer mobile devices for consuming medical and promotional content, and WhatsApp is where they already spend their screen time. But the same research found that 71% of Indian HCPs feel overwhelmed by pharma content, with product promotional content and event-related information as the primary fatigue drivers. Unstructured WhatsApp blasting accelerates that fatigue.

Practical WhatsApp etiquette within the framework: send only MLR-approved content modules, not raw PDFs or unbranded forwards. Time messages to the 8:00 pm to 11:00 pm window that Indegene identified as Indian HCPs’ preferred contact time, not mid-morning when they are with patients. Keep each message to a single content module with a clear call-to-action (register for webinar, view trial summary, review safety update), not a link dump. Never send product claims that are not in the approved label, as UCPMP 2024 clause 1.2 requires promotion to be “consistent with the terms of its marketing approval.” And always ensure the HCP has consented to receiving WhatsApp communication, which brings us to the next point.

Consent Under the DPDP Act and Rules

The Digital Personal Data Protection (DPDP) Act, 2023 was enacted on 11 August 2023, and The Digital Personal Data Protection (DPDP) Act, 2023 was enacted on 11 August 2023, and the DPDP Rules, 2025 were notified in early 2025. Penalties for breaches can reach ₹250 crore.. Penalties for breaches can reach ₹250 crore.

Under the DPDP framework, your company is a Data Fiduciary when it collects and processes HCP personal data (name, contact details, prescription patterns, engagement history). If your agency or technology vendor processes that data on your behalf, they are a Data Processor. You must: obtain explicit, verifiable consent from each HCP before processing their personal data for marketing engagement; collect only the data necessary for the specified purpose (data minimization); store HCP data within Indian jurisdiction or ensure compliant cross-border transfer; and maintain breach notification protocols, including intimating affected HCPs and the Data Protection Board within 72 hours.

For the framework, this means Layer 1 (Segmentation) must include a consent flag for every HCP: has this HCP consented to digital engagement? If yes, through which channels? If no, they remain field-force-only targets until consent is obtained. Layer 3 (Channel Orchestration) must respect these consent flags and suppress digital touchpoints for non-consented HCPs. The DPDP Rules introduce the concept of a Consent Manager, a registered entity that enables individuals to give, manage, review, and withdraw consent. Companies should monitor the Data Protection Board’s website for the Consent Manager registration process and integrate consent management into their CRM as it becomes operational.

KOL Webinars vs. Accredited CME

Indegene found that 68% of HCPs prefer webinars or webcasts as their most preferred channel for receiving information (per Indegene’s Digitally-Savvy HCP report). But not all webinars serve the same purpose, and the regulatory distinction matters.

A KOL webinar is a company-organized educational session featuring a key opinion leader discussing a therapy area, treatment guidelines, or clinical data. Under UCPMP 2024, if the webinar includes promotional content about a specific brand, that content must comply with all UCPMP provisions: claims must be consistent with the approved label, balanced, and capable of substantiation (clauses 1.2 and 1.3). The webinar must not promote off-label uses, and any comparative claims must be “factual, fair, and capable of substantiation” (clause 2.4). Brand reminders distributed at or after the webinar must not exceed ₹1,000 per item.

Accredited Continuing Medical Education (CME) is different. CME is educational content that meets the accreditation standards of a recognized medical body (such as the Medical Council of India or a state medical council). CME sessions may be sponsored by pharma companies, but the content must be independently developed and must not promote specific brands. The distinction is critical: a KOL webinar can be brand-aligned and promotional within UCPMP limits, while accredited CME must be non-promotional and independently accredited. In your framework, map KOL webinars to the awareness and consideration stages of the HCP journey (brand-relevant education), and map accredited CME to the broader medical education touchpoints that build therapeutic area credibility without brand promotion. For more on how field force training and engagement connect to broader marketing strategy, see our field force effectiveness framework.

A Sample 90-Day Rollout

The framework is buildable in 90 days if you sequence it correctly. The mistake most teams make is trying to launch all five layers simultaneously. Instead, build each layer before activating the next, so that by Day 90 you have a functioning, measured framework on a pilot brand or geography. The timeline below assumes a single brand and a single pilot territory. Scale after the pilot proves the model.

Phase	Days	Activities	Deliverable	Checkpoint Metric
Phase 1: Audit and Baseline	Days 1 to 15	Map current HCP touchpoints across all channels. Audit CRM data quality. Identify consent gaps under DPDP. Document current channel mix and call frequency by HCP tier.	Baseline engagement audit report	Percentage of HCP records with complete contact and consent data
Phase 2: Segmentation and Content Build	Days 16 to 30	Build HCP segmentation matrix using IQVIA or Pharmarack data. Draft content modules for each journey stage. Submit modules for MLR review.	Approved segmentation matrix and MLR-cleared content library	Number of content modules cleared by MLR; segment coverage percentage
Phase 3: Channel Setup and Integration	Days 31 to 45	Configure journey maps in CRM. Set up bidirectional sync between marketing automation and MR dashboard. Test consent flagging and suppression logic. Configure WhatsApp and email templates.	CRM journey maps activated; sync tested end to end	CRM sync rate in test mode (target: 100% of test engagements visible to MR within 24 hours)
Phase 4: Pilot Launch	Days 46 to 60	Activate framework for one HCP segment in one pilot territory. Run coordinated touchpoint sequence: rep visit, WhatsApp follow-up, webinar invitation, rep follow-up. Monitor daily.	Pilot live with real HCPs	Touchpoint frequency vs. target; HCP engagement rate by channel (weekly review)
Phase 5: Measure and Adjust	Days 61 to 75	Collect engagement data from all channels. Compare with baseline. Identify content modules with low completion rates. Adjust journey maps. Retire or revise underperforming modules.	Mid-pilot adjustment report	Content completion rate; channel mix adherence; MR feedback on CRM dashboard usefulness
Phase 6: Scale and Institutionalize	Days 76 to 90	Expand to additional HCP segments and territories. Codify the monthly review cycle. Document the framework as a standard operating procedure. Brief leadership on pilot results and scaling plan.	SOP document and scale plan approved by leadership	Number of HCPs in framework vs. target; engagement-to-prescription correlation trend (directional)

Two things to watch during the pilot. First, the CRM sync rate is your canary. If digital engagements are not appearing in the MR dashboard within 24 hours, the framework is not omnichannel, it is multi-channel with a data gap. Fix the integration before scaling. Second, watch for HCP fatigue signals: declining open rates, webinar no-shows, or MR feedback that doctors are mentioning repeated messages. If fatigue appears, reduce touchpoint frequency and audit whether your segmentation is too aggressive. Indegene’s finding that Indian HCPs prefer 8 to 10 monthly touchpoints across all pharma companies (per Indegene’s Digitally-Savvy HCP report) means your brand gets a fraction of that share. Every touchpoint must earn its place.

Next Steps

The five-layer framework is designed to be built sequentially, measured at each checkpoint, and adjusted monthly. Start with the baseline audit in Phase 1. If your CRM data quality is poor or your consent flags are missing, that is your first priority. No amount of content architecture or channel orchestration will compensate for a segmentation layer built on incomplete data. If you need a practitioner-level conversation about how to scope this for your specific brand, therapy area, and field force configuration, reach out at connect@pharmarketin.com. We at Pharmarketin.com are always up for a grounded discussion, and we can help you pressure-test your segmentation matrix, review your CRM integration plan, or scope the pilot territory. You can also subscribe to our newsletter for regular IPM trend breakdowns and digital adoption benchmarks that will keep your framework aligned with where the market is heading.

Frequently Asked Questions

What is an omnichannel HCP engagement framework?

It is a persistent operating model that coordinates every HCP touchpoint across channels with explicit hand-offs between five layers: segmentation, content architecture, channel orchestration, data integration, and measurement. Unlike a campaign, it is not episodic. It defines who owns each layer, what data flows between them, and how you measure whether engagement quality is improving over time.

How long does it take to build an omnichannel HCP engagement framework?

A pilot framework on a single brand and territory can be built in 90 days by sequencing the five layers: 15 days for audit and baseline, 15 for segmentation and content build, 15 for channel setup and CRM integration, 15 for pilot launch, 15 for measurement and adjustment, and 15 for scaling and institutionalizing. Each phase has a deliverable and a checkpoint metric before the next phase begins.

How does the DPDP Act affect HCP engagement in India?

Under the DPDP Act 2023 and DPDP Rules 2025 (notified 13 November 2025), pharma companies processing HCP personal data are Data Fiduciaries. They must obtain explicit consent before digital engagement, practice data minimization, store data within Indian jurisdiction or ensure compliant transfer, and maintain breach notification protocols. The framework must include a consent flag for every HCP and suppress digital touchpoints for non-consented HCPs.

What is the difference between a KOL webinar and accredited CME in pharma marketing?

A KOL webinar is a company-organized session that can include brand-relevant promotional content within UCPMP 2024 limits (claims must match the approved label and be capable of substantiation). Accredited CME is independently developed, non-promotional educational content that meets medical council accreditation standards. In the framework, KOL webinars map to awareness and consideration stages, while CME builds therapeutic area credibility without brand promotion.

How do you measure omnichannel HCP engagement success?

Core metrics include HCP engagement rate by channel, content completion rate, CRM sync rate (percentage of digital engagements visible to the MR dashboard within 24 hours), and the correlation between engagement intensity and prescription share movement. Use IQVIA or Pharmarack audit data to compare test geographies (framework active) against control geographies over at least two quarters.